Related Experiment Videos
Physiological, pharmacological and pathological factors affecting the pharmacokinetics of calcium entry blockers
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Norbormide: a calcium entry blocker with selective vasoconstrictor activity in rat peripheral arteries.
Cardiovascular drug reviews·2001
Effects of canrenone on aorta and right ventricle of the rat.
Journal of cardiovascular pharmacology·2001
Signaling mechanisms for the selective vasoconstrictor effect of norbormide on the rat small arteries.
The Journal of pharmacology and experimental therapeutics·2001
Callipeltin A, a cyclic depsipeptide inhibitor of the cardiac sodium-calcium exchanger and positive inotropic agent.
Biochemical and biophysical research communications·2000
Effect of long-term ouabain treatment on contractile responses of rat aortae.
Journal of cardiovascular pharmacology·2000
Myocardial region (right or left ventricle) and aetiology of heart failure can influence the inotropic effect of ouabain in failing human myocardium.
British journal of clinical pharmacology·1999
Cardiac tamponade: an unusual, fatal complication of infective endocarditis.
Giornale italiano di cardiologia·2000
Treatment of a native right coronary artery with the PercuSurge Guardwire protection system during PTCA and stenting.
Giornale italiano di cardiologia·2000
Relief of an early pulmonary pathway obstruction with stenting after modified Fontan operation in an adult.
Giornale italiano di cardiologia·2000
[Clinical characteristics, familial distribution and preliminary genetic data in 9 different families with "Brugada's syndrome"].
Giornale italiano di cardiologia·2000
[Clinical course of pre- and post-natal isolated congenital atrioventricular block diagnosed in utero].
Giornale italiano di cardiologia·2000
Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.
The Journal of membrane biology·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026